Publication|Articles|February 18, 2026
- Pharmaceutical Executive: February 2026
- Volume 46
- Issue 1
Pharmaceutical Executive: February 2026 Interactive Digital Edition
View the Pharmaceutical Executive February 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
6 months ago
A New Pharma Playbook6 months ago
When Friction Meets Force in Clinical Research6 months ago
Today’s China Crucible: What It Means for Pharma6 months ago
Taking Advantage of ‘Hidden Gem’ Talent Hubs7 months ago
To Build or to Buy: Determining Your AI PathAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Legal Risk in a Rumored AstraZeneca-BMS Deal: Q&A with Ron Lanton
2
FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma
3
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
4
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million
5
